Mangoceuticals, Inc. (MGRX)
MGRXNASDAQ-CMMisc Health and Biotechnology Services
$0.1998
+0.0031 (+1.58%) today
Regular session, Nov 12, 12:03 PM ET
- Market cap
- $4.44m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.1800 to $0.2000
- 52-week range
- $0.1620 to $2.28
- Average volume
- –
- Previous close
- $0.1967
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $84.0k | $94.0k | $68.0k | $69.0k |
| Gross profit | $51.0k | $47.0k | $29.0k | $44.0k |
| Operating income | -$7.54m | -$368.0k | -$3.13m | -$1.03m |
| Net income | -$7.62m | -$2.77m | -$3.40m | -$1.31m |
Last four quarters: revenue $315.0k, margin -4794.9%, free cash flow –
News
8 latest- Mangoceuticals, Inc. Announces Proposed Series D Preferred Stock Terms and Combined 2025 and 2026 Annual Meeting DateFintel · 6 days ago
- Mangoceuticals Secures $2.5 Mln Investment To Advance Antiviral IP Commercialization RTTNews · Oct 2, 2026
- Mangoceuticals To Merge With Nuclea Energy, Advancing Nuclear Microreactor; Stock Up RTTNews · Jul 31, 2026
- Big Move In Solana: 2 Reasons Why This Top Token Surged 7% Off Yesterday's BottomThe Motley Fool · Dec 19, 2025
- Mangoceuticals, Inc. Reports 100% Survival Rates in Field Studies of MGX-0024 for Poultry Respiratory DiseasesQuiver Quantitative · May 27, 2025
- Mangoceuticals Enters Wellness Pouch Market, Appoints Tim Corkum To Lead New Unit RTTNews · Apr 25, 2025
- Mangoceuticals Inc. Acquires Intellectual Property Assets from Smokeless Technology Corp. to Expand into Oral Pouch Delivery MarketQuiver Quantitative · Apr 25, 2025
- Mangoceuticals Secures Exclusive Rights for Plant-Based Nutriceutical Diabetinol® to Address Pre-Diabetes and Weight Management Market in U.S. and CanadaQuiver Quantitative · Mar 25, 2025
The company
MangoRx is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. The Company currently offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction, hair growth, hormone replacement therapies, and weight management. Interested consumers can use MangoRx's telemedicine platform for a smooth experience. Prescription requests will be reviewed by a licensed medical provider and, if approved, fulfilled and discreetly shipped through MangoRx's partner compounding pharmacy and right to the patient's doorstep.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- mangoceuticals.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.